Answer
Avacopan selectively blocks the C5a receptor C5aR1, preventing C5a interaction and reducing its pro-inflammatory effects, including neutrophil activation, migration and adherence at inflamed small blood vessels, and vascular endothelial cell retraction and permeability.
Sources for this answer
- Avacopan Vifor 10 mg hard capsulesVifor Fresenius Medical Care Renal Pharma UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 7Document updated
Sources checked